Role of antibodies in controlling viral disease: Lessons from experiments of nature and gene knockouts

Journal of Virology

Volumn 74, Issue 21, 2000, Pages 9813-9817

  Sanna, P P ^a   Burton, D R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ANIMAL MODEL; ANTIBODY RESPONSE; BACTERIAL INFECTION; CELLULAR IMMUNITY; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; HUMAN; HUMORAL IMMUNE DEFICIENCY; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME; VACCINATION; VIRUS INFECTION;

AGAMMAGLOBULINEMIA; ANIMAL; ANTIBODIES, VIRAL; GENE DELETION; HUMAN; MICE; SUPPORT, U.S. GOV'T, P.H.S.; VIRUS DISEASES;

EID: 0033781902     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.21.9813-9817.2000     Document Type: Short Survey

References (89)

1. Paralytic poliomyelitis in a child with agammaglobulinemia
2. Development of immunoglobulin preparations for intravenous use
3. Intravenous administration of human gamma-globulin
4. The spectrum of primary immunodeficiency disorders in Australia
5. Cutaneous manifestations of immunogenetic deficiency disorders
6. Fatal chronic cutaneous herpes simplex associated with thymoma and hypogammaglobulinaemia
7. B cell-deficient mice have increased susceptibility to HSV-1 encephalomyelitis and mortality
8. Agammaglobulinemia
9. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody
10. Breakthroughs in the understanding and therapy of primary immunodeficiency
11. Structure and function of natural antibodies
12. Childhood common variable immunodeficiency with autoimmune disease
13. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency
14. Resistance to herpetic stromal keratitis in immunized B-cell-deficient mice
15. Determinants of polyreactivity in a large panel of recombinant human antibodies from HIV-1 infection
16. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease
17. Immune protection against HSV-2 in B-cell-deficient mice
18. Common variable immunodeficiency: Diagnosis and management
19. Poxviruses
20. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice
21. Alterations in expression of measles virus polypeptides by antibody: Molecular events in antibody-induced antigenic modulation
22. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion
23. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of friend leukemia virus
24. Disturbances in gamma globulin synthesis as 'experiments of nature'
25. Immunodeficiency measles encephalitis
26. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice
27. Subacute encephalitis and hypogammaglobulinemia
28. Antigenic analysis of polioviruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration
29. Primary immunodeficiency syndrome in Japan. I. Overview of a nationwide survey on primary immunodeficiency syndrome
30. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course
31. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus
32. Pathogenesis of herpes simplex virus in B cell-suppressed mice: The relative roles of cell-mediated and humoral immunity
33. Neutropenia associated with X-linked agammaglobulinaemia
34. Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice
35. X-linked agammaglobulinemia: An analysis of 96 patients
36. Antibody-mediated clearance of alphavirus infection from neurons
37. Antibody-induced restriction of viral gene expression in measles encephalitis in rats
38. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia
39. Fatal viral encephalitis in children with X-linked hypogammaglobulinemia
40. Chronic progressive encephalitis in children with x-linked hypogammaglobulinemia
41. Primary immunodeficiency syndrome in Spain: First report of the national registry in children and adults
42. Host defenses in herpes simplex infections of the nervous system: Effect of antibody on disease and viral spread
43. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients
44. Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice
45. Evidence that resolution of infection in mice is due to both CD4- and CD8-dependent activities
46. Chronic progressive panencephalitis in hypogammaglobulinemia
47. The mouse model and understanding immunity to herpes simplex virus
48. Neutralizing antibodies inhibit the axonal spread of herpes simplex virus type 1 to epidermal cells in vitro
49. Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID)
50. Chronic enteroviral meningoencephalitis in agammaglobulinemia: Case report and literature review
51. Various immunoglobulin preparations for intravenous use
52. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety
53. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection
54. Antibody-induced modulation of proteins in vesicular stomatitis virus-infected fibroblasts
55. Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia
56. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases
57. X-linked agammaglobulinemia. A clinical and molecular analysis
58. Control of early viral and bacterial distribution and disease by natural antibodies
59. Fatal progressive vaccinia in two immunodeficient infants
60. Chronic cutaneous herpes simplex and X-linked hypogammaglobulinemia
61. + T cells in murine resistance to street rabies virus
62. Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo
63. The long term treatment of childhood hypogammaglobulinaemia in Melbourne with intravenous gammaglobulin, 1972-1985
64. Encephalomyelitis in primary hypogamma-globulinaemia
65. Primary immunodeficiencies in Switzerland: First report of the national registry in adults and children
66. Progressive encephalopathy associated with X-linked agammaglobulinemia
67. Vaccine-associated poliomyelitis in an infant with agammaglobulinemia
68. Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV
69. Localization of a passively transferred human recombinant monoclonal antibody to herpes simplex virus glycoprotein D to infected nerve fibers and sensory neurons in vivo
70. Chronic rotavirus infection in immunodeficiency
71. Worldwide epidemiology of human adenovirus infections
72. Diagnosis criteria and classification of human primary defects of tumoral immunity
73. Fatal disseminated adenovirus 11 pneumonia in an agammaglobulinemic patient
74. Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus
75. Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973-1993
76. Common variable immunodeficiency: How many diseases?
77. Herpes simplex viruses 1 and 2
78. Human intravenous immunoglobulin in primary and secondary antibody deficiencies
79. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
80. Protective anti-reovirus monoclonal antibodies and their effects on viral pathogenesis
81. The gene involved in X-linked agammaglobulinaemia is a member of the Src family of protein-tyrosine kinases
82. B cells regulate murine gammaherpesvirus 68 latency
83. Herpes simplex viruses
84. Viral encephalitis
85. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia
86. Herpes simplex encephalitis in a premature infant with complete lack of immune globulin IgA
87. Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia
88. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia
89. Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab')2 fragments protect mice from vaginal transmission of HSV-2